Updated

A twice-yearly injection has emerged as a potential breakthrough in HIV prevention, described as 'the closest thing to an HIV vaccine.' The development promises to revolutionize approaches to combating HIV transmission. However, questions remain unresolved regarding equitable global access to the treatment and its availability across different regions and populations.